John R. Stuelpnagel - 17 Jun 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
17 Jun 2021
Net transactions value
-$996,921
Form type
4
Filing time
21 Jun 2021, 17:07:54 UTC
Previous filing
15 Jun 2021
Next filing
06 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $19,097 -100 -0.02% $190.97 406,516 17 Jun 2021 Direct F1
transaction TXG Class A Common Stock Sale $19,197 -100 -0.02% $191.97 406,416 17 Jun 2021 Direct F1
transaction TXG Class A Common Stock Sale $39,059 -200 -0.05% $195.30 406,216 17 Jun 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale $78,699 -400 -0.1% $196.75 405,816 17 Jun 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale $98,874 -500 -0.12% $197.75 405,316 17 Jun 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale $119,581 -600 -0.15% $199.30 404,716 17 Jun 2021 Direct F1, F5
transaction TXG Class A Common Stock Sale $340,393 -1,700 -0.42% $200.23 403,016 17 Jun 2021 Direct F1, F6
transaction TXG Class A Common Stock Sale $201,026 -1,000 -0.25% $201.03 402,016 17 Jun 2021 Direct F1, F7
transaction TXG Class A Common Stock Sale $60,653 -300 -0.07% $202.18 401,716 17 Jun 2021 Direct F1, F8
transaction TXG Class A Common Stock Sale $20,342 -100 -0.02% $203.42 401,616 17 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $194.99 to $195.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $196.36 to $197.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $197.48 to $198.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $198.72 to $199.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $199.725 to $200.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $200.74 to $201.32. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $201.825 to $202.68. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.